Quality of Life 1y and 2 y After VV-ECMO for COVID-19

NCT05780255 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 28

Last updated 2024-04-25

No results posted yet for this study

Summary

This study aims to investigate the quality of life and the outcome after veno-venous extracoporeal membrane oxygenation (ECMO) support fir severe acute respiratory syndrome (ARDS) in COVID-19 patients.

Conditions

  • COVID-19 Acute Respiratory Distress Syndrome
  • Extracorporeal Membrane Oxygenation Complication
  • Quality of Life
  • Death

Interventions

DEVICE

VV-ECMO

veno-venous extracorporeal membrane oxygenation

Sponsors & Collaborators

  • University Hospital, Ghent

    lead OTHER

Principal Investigators

  • Harlinde Peperstraete · UZ Gent

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-20
Primary Completion
2023-01-31
Completion
2024-02-01

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05780255 on ClinicalTrials.gov